Infinity Diagnostics Laboratory, INC

Infinity Diagnostics Laboratory, INC was paid $138.00M by Medicaid between Jan 2018 and May 2023, across 76 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 71% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in New Jersey

Rank by total paid#5 of 122

Median peer was paid$1.29M

This provider vs. median107×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	20,469	$197K
2019	21,345	$393K
2020	18,402	$1.32M
2021	275,939	$9.57M
2022	4,689,175	$126.06M
2023	143,820	$458K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	71%	2,288,473	579,127	$97.30M
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	23%	2,269,809	568,997	$31.77M
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	5.9%	547,597	208,214	$8.13M
G0483	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed	<1%	2,057	961	$389K
86769		<1%	6,267	5,529	$180K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	1,570	721	$85K
G0482	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed	<1%	309	293	$36K
80061	Lipid panel	<1%	5,249	5,050	$17K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	3,164	3,028	$16K
80050	General health panel	<1%	1,165	1,067	$12K
83036	Hemoglobin; glycosylated (A1C)	<1%	4,366	4,193	$5K
80053	Comprehensive metabolic panel	<1%	4,121	3,926	$5K

64 more codes

84439		<1%	2,491	$5K
82607		<1%	962	$5K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	304	$4K
84443	Thyroid stimulating hormone (TSH)	<1%	2,338	$4K
84480		<1%	971	$3K
86003		<1%	101	$3K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	4,035	$3K
84153		<1%	624	$3K
86803		<1%	286	$2K
82746		<1%	711	$2K
82728		<1%	526	$2K
86706		<1%	259	$1K
84378		<1%	524	$1K
84154		<1%	161	$1K
83550		<1%	561	$1K
83540		<1%	1,191	$925.23
84550		<1%	1,763	$858.36
80048	Basic metabolic panel (calcium, ionized)	<1%	287	$763.23
86704		<1%	152	$753.36
87086	Culture, bacterial; quantitative colony count, urine	<1%	531	$667.94
87340		<1%	147	$663.77
82785		<1%	98	$542.16
82378		<1%	74	$535.85
81001		<1%	2,055	$534.27
82248		<1%	757	$511.10
80076		<1%	320	$503.90
86708		<1%	118	$470.09
82977		<1%	739	$456.24
86141		<1%	105	$432.01
84100		<1%	990	$416.26
83615		<1%	612	$381.58
83735		<1%	526	$371.48
86592		<1%	332	$357.68
86038		<1%	186	$331.43
82043		<1%	1,014	$310.99
85610		<1%	455	$273.96
84436		<1%	364	$261.36
85651		<1%	652	$242.93
81003		<1%	1,653	$241.38
83721		<1%	124	$208.03
36415	Collection of venous blood by venipuncture	<1%	2,687	$203.70
87184		<1%	98	$195.28
87070		<1%	60	$160.59
83970		<1%	13	$136.96
87077		<1%	45	$130.40
86140		<1%	144	$129.00
85045		<1%	182	$125.20
87081		<1%	55	$108.76
86304		<1%	28	$101.06
87088		<1%	109	$86.13
86430		<1%	225	$73.80
82570		<1%	236	$53.40
82150		<1%	26	$49.50
83690		<1%	24	$40.50
99001		<1%	766	$36.00
86376		<1%	12	$33.00
82272		<1%	24	$23.28
P9604	Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge	<1%	19	$20.20
84479		<1%	40	$19.00
85730		<1%	18	$12.00
86060		<1%	33	$7.20
82274		<1%	28	$3.70
82465		0%	19	$0.00
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	0%	13	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialLOVEY, JOSEPH (MANAGER)